Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Quattro74on Aug 22, 2020 9:25am

291 Views

Post# 31441355

RE:RE:RE:RE:RE:RE:RE:Covid 19 IS the promotor

Yep, ha ha nice rabit/hat analogy. Very true. I think that FT or maybe even BTD could be out by AGM. That would be amazing. I think it is based on Phase 1 results so 66%? Also, some more info on their Covid 19 tech. It looks like they can take their ACT tech and apply it directly to Covid? Would be amazing to have basically a free Phase 1 on the ACT and maybe a free nsclc Phase 1 from Roswell Park while their phase 2 nmibc gets FT.

Bullboard Posts

Visionstate set to leverage success in the U.S. market